CoChat
Sign Up
Cited by 181

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

MicroRNA-155 Targets SMAD2 and Modulates the Response of Macrophages to Transforming Growth Factor-β

Louafi, Fethi, Martinez-Nunez, Rocio T., Sanchez-Elsner, Tilman·2010·Journal of Biological Chemistry
DOI 10.1074/jbc.m110.146852
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m110.146852

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Figures

Image 1
CC-BY · From the PDF
FIGURE 2 SMAD2proteinlevelsaredown-regulatedwhenTHP1-155cells overexpress miR-155. A , THP1-155 were treated or not with doxycycline ( Dox ) to de-repress or not the expression of miR-155 transgene, respectively. Cells were collected at different time point and subjected to RNA extraction; cell lysate of the same samples were also collected. RNA from these samples wasusedtoquantify miR-155 and the housekeeping RNU44 levels with a specific microRNA RT-qPCR. All values are expressed as -fold induction of the nontreated THP1-155 cells (time = 0 h). B , protein extract from the same sample wassubjected to Western blotting, and SMAD2 levels were determined. As a normalizing control, 𝛃 -actin was also detected in the same blot. Values represent percentages of SMAD2 normalized against 𝛃 -actin and compared with control. C , the same RNA was extracts were also used to perform a standard RT-qPCR to determine SMAD2 mRNA levels. Values were normalized against GAPDH.
FIGURE 2 SMAD2proteinlevelsaredown-regulatedwhenTHP1-155cells overexpress miR-155. A , THP1-155 were treated or not with doxycycline ( Dox ) to de-repress or not the expression of miR-155 transgene, respectively. Cells were collected at different time point and subjected to RNA extraction; cell lysate of the same samples were also collected. RNA from these samples wasusedtoquantify miR-155 and the housekeeping RNU44 levels with a specific microRNA RT-qPCR. All values are expressed as -fold induction of the nontreated THP1-155 cells (time = 0 h). B , protein extract from the same sample wassubjected to Western blotting, and SMAD2 levels were determined. As a normalizing control, 𝛃 -actin was also detected in the same blot. Values represent percentages of SMAD2 normalized against 𝛃 -actin and compared with control. C , the same RNA was extracts were also used to perform a standard RT-qPCR to determine SMAD2 mRNA levels. Values were normalized against GAPDH.CC-BY · From the PDF
FIGURE 3 In THP1-155 cells TGF 𝛃 1-induced increases of phosphoSMAD2, protein levels are reduced when miR-155 is overexpressed. THP1-155 cells were cultured with or without doxycycline for 96 h, then cells were starved for 12 h before the addition of TGF 𝛃 1 (10 ng/ml). Lysates of these cells were taken after 1, 2, and 3 h to quantify the levels of phospho-SMAD2/SMAD2 and phospho-SMAD3/SMAD3 protein by Western immunoblotting. As a normalizing control, 𝛃 -actin was also detected in the same blot. Densitometry values across the top represent the percentage of phospho-SMAD2 normalized against 𝛃 -actin and compared with control.
FIGURE 3 In THP1-155 cells TGF 𝛃 1-induced increases of phosphoSMAD2, protein levels are reduced when miR-155 is overexpressed. THP1-155 cells were cultured with or without doxycycline for 96 h, then cells were starved for 12 h before the addition of TGF 𝛃 1 (10 ng/ml). Lysates of these cells were taken after 1, 2, and 3 h to quantify the levels of phospho-SMAD2/SMAD2 and phospho-SMAD3/SMAD3 protein by Western immunoblotting. As a normalizing control, 𝛃 -actin was also detected in the same blot. Densitometry values across the top represent the percentage of phospho-SMAD2 normalized against 𝛃 -actin and compared with control.CC-BY · From the PDF
FIGURE 4 A , overexpression of miR-155 reduces the TGF𝛃 dependent transcriptional activity. THP1-155 cells were treated with or without doxycycline for 96 h to de-repress or not the expression of the miR-155 transgene. Cells were then treated or not with TGF𝛃 1 (10 ng/ml) for 48 and assayed in RT-qPCR to determine the levels of SERPINE1 mRNA. B , THP-1 cells were transfected with pre-miR-155, pre-miR-221, or pre-miR control oligonucleotides. 48 h after transfection, cells were treated or not with TGF𝛃 1 for an additional 48 h period and then assayed by RT-qPCR to determine the levels of SERPINE1 mRNA. C , THP-1 cells were transfected with different siRNAs: anti-SMAD2#1, anti-SMAD2#2, and siRNA-Control#1. 48 h after transfection cells were treated or not with TGF𝛃 1 for an additional 48 h period and then assayed by RT-qPCR to determine the levels of SERPINE1 mRNA. D , THP1155 cells were treated with doxycycline as in A . Cells were then transfected with the CAGA12 LUC vector and pRLTK vector as a normalizing vector. Cells were then starved for 12 h before the addition or not of TGF𝛃 1 (10 ng/ml). 24 h later cell lysates were collected and subjected to a dual luciferase activity assay. Values in D represent a percentage of luciferase activity (CAGA12LUC) normalized against renilla luciferase (pRLTK) and compared with control. Values in A-C were normalized against GAPDH and are presented as -fold induction versus the non-treated cells. Statistical significant difference ( p ≤ 0.05) is shown as asterisks and p ≤ 0.01 is shown as double asterisks .
FIGURE 4 A , overexpression of miR-155 reduces the TGF𝛃 dependent transcriptional activity. THP1-155 cells were treated with or without doxycycline for 96 h to de-repress or not the expression of the miR-155 transgene. Cells were then treated or not with TGF𝛃 1 (10 ng/ml) for 48 and assayed in RT-qPCR to determine the levels of SERPINE1 mRNA. B , THP-1 cells were transfected with pre-miR-155, pre-miR-221, or pre-miR control oligonucleotides. 48 h after transfection, cells were treated or not with TGF𝛃 1 for an additional 48 h period and then assayed by RT-qPCR to determine the levels of SERPINE1 mRNA. C , THP-1 cells were transfected with different siRNAs: anti-SMAD2#1, anti-SMAD2#2, and siRNA-Control#1. 48 h after transfection cells were treated or not with TGF𝛃 1 for an additional 48 h period and then assayed by RT-qPCR to determine the levels of SERPINE1 mRNA. D , THP1155 cells were treated with doxycycline as in A . Cells were then transfected with the CAGA12 LUC vector and pRLTK vector as a normalizing vector. Cells were then starved for 12 h before the addition or not of TGF𝛃 1 (10 ng/ml). 24 h later cell lysates were collected and subjected to a dual luciferase activity assay. Values in D represent a percentage of luciferase activity (CAGA12LUC) normalized against renilla luciferase (pRLTK) and compared with control. Values in A-C were normalized against GAPDH and are presented as -fold induction versus the non-treated cells. Statistical significant difference ( p ≤ 0.05) is shown as asterisks and p ≤ 0.01 is shown as double asterisks .CC-BY · From the PDF
Image 5
CC-BY · From the PDF
Image 6
CC-BY · From the PDF
Image 7
CC-BY · From the PDF
FIGURE 5 Expression of SMAD2-dependent and -independent genes in THP1-155 cells overexpressing miR-155. THP1-155 cells were treated with or without doxycycline for 96 h, then starved for 12 h before the addition of TGF𝛃 1 (10 ng/ml). 48 h later RNA from these cells was extracted and subjected to RT-qPCR to determine the levels of mRNA of TGF𝛃 1, TGF𝛃 2, TGF𝛃 3, ICAM1, VEGF, IL-1 𝛃 , MMP9, IL-4R, DC-SIGN, and SMAD2. Values were normalized against GAPDH and are presented as -fold induction versus the non-treated cells. RNA from the same sample was subjected to a specific micro-RNA RTqPCR to quantify levels of miR-155. Values were normalized to the housekeeping RNU44. Statistical significant difference ( p ≤ 0.05) is shown as asterisks .
FIGURE 5 Expression of SMAD2-dependent and -independent genes in THP1-155 cells overexpressing miR-155. THP1-155 cells were treated with or without doxycycline for 96 h, then starved for 12 h before the addition of TGF𝛃 1 (10 ng/ml). 48 h later RNA from these cells was extracted and subjected to RT-qPCR to determine the levels of mRNA of TGF𝛃 1, TGF𝛃 2, TGF𝛃 3, ICAM1, VEGF, IL-1 𝛃 , MMP9, IL-4R, DC-SIGN, and SMAD2. Values were normalized against GAPDH and are presented as -fold induction versus the non-treated cells. RNA from the same sample was subjected to a specific micro-RNA RTqPCR to quantify levels of miR-155. Values were normalized to the housekeeping RNU44. Statistical significant difference ( p ≤ 0.05) is shown as asterisks .CC-BY · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 34

  1. Massagué, 2000, Nat. Rev. Mol. Cell Biol., 1, 169, 10.1038/35043051 · DOI
  2. Sánchez-Elsner, 2001, J. Biol. Chem., 276, 38527, 10.1074/jbc.M104536200 · DOI
  3. Khalil, 2001, Thorax., 56, 907, 10.1136/thorax.56.12.907 · DOI
  4. Geissmann, 1999, J. Immunol., 162, 4567, 10.4049/jimmunol.162.8.4567 · DOI
  5. Padua, 2009, Cell Res., 19, 89, 10.1038/cr.2008.316 · DOI
  6. Massagué, 1998, Annu. Rev. Biochem., 67, 753, 10.1146/annurev.biochem.67.1.753 · DOI
  7. Massagué, 2000, EMBO J., 19, 1745, 10.1093/emboj/19.8.1745 · DOI
  8. Inui, 2010, Nat. Rev. Mol. Cell Biol., 11, 252, 10.1038/nrm2868 · DOI
  9. Lai, 2002, Nat. Genet., 30, 363, 10.1038/ng865 · DOI
  10. Brennecke, 2005, PLoS Biol., 3, e85, 10.1371/journal.pbio.0030085 · DOI
  11. Bushati, 2007, Annu. Rev. Cell Dev. Biol., 23, 175, 10.1146/annurev.cellbio.23.090506.123406 · DOI · Paper page
  12. Martin, 2006, J. Biol. Chem., 281, 18277, 10.1074/jbc.M601496200 · DOI
  13. Kong, 2008, Mol. Cell Biol., 28, 6773, 10.1128/MCB.00941-08 · DOI
  14. Tili, 2009, Int. Rev. Immunol., 28, 264, 10.1080/08830180903093796 · DOI
  15. O'Connell, 2007, Proc. Natl. Acad. Sci. U.S.A., 104, 1604, 10.1073/pnas.0610731104 · DOI · Paper page
  16. Martinez-Nunez, 2009, J. Biol. Chem., 284, 16334, 10.1074/jbc.M109.011601 · DOI
  17. Stanczyk, 2008, Arthritis Rheum., 58, 1001, 10.1002/art.23386 · DOI
  18. Jiang, 2010, Cancer Res., 70, 3119, 10.1158/0008-5472.CAN-09-4250 · DOI · Paper page
  19. Lewis, 2003, Cell., 115, 787, 10.1016/S0092-8674(03)01018-3 · DOI · Paper page
  20. Dennler, 1998, EMBO J., 17, 3091, 10.1093/emboj/17.11.3091 · DOI
  21. Li, 2006, Annu. Rev. Immunol., 24, 99, 10.1146/annurev.immunol.24.021605.090737 · DOI
  22. Senoo, 2010, Thorax., 65, 334, 10.1136/thx.2009.119974 · DOI
  23. Min, 2010, Biochem. Biophys. Res. Commun., 393, 536, 10.1016/j.bbrc.2010.02.050 · DOI
  24. ten Dijke, 2007, Nat. Rev. Mol. Cell Biol., 8, 857, 10.1038/nrm2262 · DOI
  25. Bonniaud, 2004, J. Immunol., 173, 2099, 10.4049/jimmunol.173.3.2099 · DOI
  26. Bossé, 2007, Respir. Res., 8, 66, 10.1186/1465-9921-8-66 · DOI
  27. Pottier, 2009, PLoS One., 4, e6718, 10.1371/journal.pone.0006718 · DOI
  28. Parihar, 2010, J. Innate Immun., 2, 204, 10.1159/000296507 · DOI
  29. Shih, 2001, Growth Factors., 19, 19, 10.3109/08977190109001073 · DOI
  30. Ceppi, 2009, Proc. Natl. Acad. Sci. U.S.A., 106, 2735, 10.1073/pnas.0811073106 · DOI · Paper page
  31. Rai, 2010, Proc. Natl. Acad. Sci. U.S.A., 107, 3111, 10.1073/pnas.0910667107 · DOI
  32. Pohlers, 2009, Biochim. Biophys. Acta., 1792, 746, 10.1016/j.bbadis.2009.06.004 · DOI
  33. Monteleone, 2001, J. Clin. Invest., 108, 601, 10.1172/JCI12821 · DOI
  34. Ralser, 2006, Biochem. Biophys. Res. Commun., 347, 747, 10.1016/j.bbrc.2006.06.151 · DOI

Cited by

Sorted by citations

See all 181

Metadata

Authors
Louafi, F., Martinez-Nunez, R. T., & Sanchez-Elsner, T.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2010-12
Volume
285
Issue
53
Pages
41328-41336
ISSN
0021-9258
DOI
10.1074/jbc.m110.146852
Cited by
181
References
1
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: MicroRNA-155 Targets SMAD2 and Modulates the Response of Macrophages to Transforming Growth Factor-β. https://app.cochat.ai/papers/10.1074/jbc.m110.146852
The paper
Louafi, F., Martinez-Nunez, R. T., & Sanchez-Elsner, T. (2010). MicroRNA-155 Targets SMAD2 and Modulates the Response of Macrophages to Transforming Growth Factor-β. Journal of Biological Chemistry. https://doi.org/10.1074/jbc.m110.146852